MCADDI 2026
Medicinal Chemistry, Drug Discovery & Development India
The complete journey — from target identification to clinical development
Where Chemistry Meets Clinical Reality
MCADDI is a globally recognized program presenting the full spectrum of drug discovery and development — from medicinal chemistry principles to advanced biologics, clinical translation, and manufacturing.
MCADDI 2026 marks a landmark edition — brought to Hyderabad for the first time in collaboration with FABA, Science Gurus, and the University of Hyderabad.
Global industry & academic faculty
Speakers from BMS, Genentech, AbbVie, Merck, Amgen, Sun Pharma and more.
Interactive case-based sessions
Real drug discovery case histories from concept to approved medicine.
CEO conclave & keynote banquet
Exclusive fireside chat with pharma CEOs + networking banquet.
Novel modalities & AI in pharma
Sessions on ADCs, PROTACs, biologics & AI-driven drug design.
A Decade of Excellence
Key Thematic Areas
30+ lectures spanning the complete drug discovery and development paradigm —
from first principles to the clinic.
- Target identification & validation
- Principles of medicinal chemistry
- Hit identification, HTS & virtual screening
- Hit-to-lead & lead optimization
- Structure-based & AI-driven drug design
- Molecular modelling & in silico tools
- Drug-like & physicochemical properties
- Drug metabolism & pharmacokinetics
- Bioisosteres & prodrugs in drug design
- Designing around toxicophores
- Preclinical & translational ADME/PK
- Clinical development & regulatory pathways
- Biopharmaceutics & formulation
- Process chemistry & manufacturing
- Biologics & monoclonal antibodies
- Antibody-drug conjugates (ADCs)
- Protein degraders & molecular glues
- G-protein coupled receptors
- AI in pharma & biotech
- Enzymes, receptors & ion channels
- Integrated drug discovery case histories
Program Highlights
6-Day Program Structure
Each day runs from 8:30 AM with lectures, case studies, and networking breaks. One evening features the CEO conclave and banquet.
- Registration from 11:00 AM
- Welcome address
- Principles of medicinal chemistry (Parts 1 & 2)
- Target identification & validation
- Reception & dinner
- Hit identification, HTS & virtual screening
- Drug-like & physicochemical properties
- Enzymes, receptors & ion channels
- Molecular interactions & structure-based design
- Hit-to-lead & lead optimization
- In silico tools & AI in drug discovery
- G-protein coupled receptors
- Bioisosteres in drug design
- Drug metabolism, PK & disposition
- Preclinical to clinical translational ADME
- Prodrugs in drug discovery
- Introduction to biologics (Parts 1 & 2)
- Antibody-drug conjugates (ADCs)
- Protein degraders & molecular glues
- Biopharmaceutics & developability
- CEO conclave & fireside chat
- Evening reception & banquet
- Designing around toxicophores
- Process chemistry & manufacturing
- Integrated drug discovery case histories
- AI applications in pharma & biotech
- Applications of heterocycles in drug design
- First-in-class drug discovery case history
- Concluding remarks & certificate distribution
- Daily coffee & tea breaks
- Lunch & learn sessions (industry sponsors)
- Exhibition hall & sponsor booths
- CEO conclave & fireside chat
- Evening reception & banquet
- AI-driven drug design & discovery
- Machine learning in medicinal chemistry
- In silico screening & molecular modelling
- Real-world AI case studies from industry
- Panel discussion on AI in pharma & biotech
What You Get
Frequently Asked Questions
Faculty 2026
Speakers
Tom Prisinzano
University of Kentucky, USA
Principles of Medicinal Chemistry Drug-Like Properties
Manjunath Ramarao
Aragen, India/USA
Target ID · Hit ID/HTS · Enzymes & Receptors · GPCRs
Ralf Glatthar
Novartis, USA
Hit-to-Lead & Lead Optimization
Vincent (Vinnie) Stoll
AbbVie, USA
Molecular Interactions · Structure-Based Drug Design
Rachel Lagiakos
Novartis, USA
Principles of Medicinal Chemistry Drug-Like Properties
Punit Marathe
BMS / Agios, USA
Drug Metabolism & PK · Clinical Pharmacology · ADME/PK/PD
Nick Meanwell
Baruch S. Blumberg Institute, USA
Prodrugs · Bioisosteres · Toxicophores · Heterocycles · Fostemsavir
Ramesh Kashi
Ex-BMS / Merck, USA
Biopharmaceutics · Subcutaneous Biologics
Rustom Mody
Sun Pharma, India
Introduction to Biologics (Parts 1 & 2)
Nitin Damle
Sun Pharma, India
Principles of ADCs · ADC Case Study
Martin Eastgate
Bristol-Myers Squibb, USA
Process Chemistry · Integrated Process Development
Mukul Jain
Zydus Lifesciences, India
Case Study – Metabolic Disease
Murali Ramachandra
Aurigene Oncology, India
Case Study – Oncology
Jagath Reddy
Aarvik Therapeutics, USA
Case Study – ADC Linker Chemistry · PROTACs · Degraders · Molecular Glues
Ratnakar Palakodeti
SCIINV Biosciences
Case Study – AI-Based Drug Design Case Study
CSN Murthy
Satya Pharma Innovation, India
Case Study – RAD51BRCA2 Inhibitor – Pan-Cancer Drug
MS Reddy
CDED, India
Targeted Protein Degraders & Molecular Glues
Speakers
We are finalizing an outstanding faculty from global pharma, biotech, and academia. Check back soon for the confirmed speaker list.
Past Edition Speakers
MCADDI 2024 featured 17 exceptional speakers from leading global institutions. Expect a similarly distinguished lineup for 2026.
* Speaker list above is from MCADDI 2024. MCADDI 2026 speakers will be announced shortly.
Who Should Attend
Supported By





ACS American Chemical Society · Medicinal Chemistry Division
IUPAC Human Health DivisionRegistration
Researchers · Faculty
Click below to complete your registration and payment securely. Early registration is strongly recommended — seats are limited.
Register via FABAPayment processed securely through FABA · www.biofaba.org.in
For queries: info@biofaba.org.in · +91 7989957263
Contact Us
Gachibowli, Hyderabad – 500032
Gachibowli, Hyderabad – 500046